Indivior to Report Q1 2026 Earnings, Host Webcast

Pharmaceutical company Indivior will announce its first quarter 2026 financial results and host a live webcast presentation for investors.

Apr. 9, 2026 at 1:33pm

Got story updates? Submit your updates here. ›

A high-contrast black and white macro photograph of the intricate gears, valves, and machinery inside a pharmaceutical production facility, conveying the complex industrial processes involved in manufacturing addiction treatment drugs.The behind-the-scenes machinery and processes that power Indivior's pharmaceutical production for addiction treatment medications.Richmond Today

Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) announced it will report its first quarter 2026 financial results on Thursday, April 30, 2026, at 7:00 a.m. U.S. EDT. Following the release, CEO Joe Ciaffoni and other company leaders will host a live webcast presentation at 8:00 a.m. U.S. EDT. The webcast and materials can be accessed on Indivior's investor relations website, and participants can also access the presentation telephonically.

Why it matters

As a leader in treatments for opioid use disorder, Indivior's quarterly financial results and updates provide insight into the state of the addiction treatment market and the company's ongoing efforts to develop and commercialize its products.

The details

Indivior will report its Q1 2026 financial results before the market opens on April 30, 2026. Following the release, CEO Joe Ciaffoni and other members of Indivior's leadership team will host a live webcast presentation at 8:00 a.m. U.S. EDT to discuss the results. The webcast and materials can be accessed on the company's investor relations website, and participants can also access the presentation telephonically by registering through a provided link.

  • Indivior will report Q1 2026 financial results on April 30, 2026 at 7:00 a.m. U.S. EDT.
  • Indivior will host a live webcast presentation on April 30, 2026 at 8:00 a.m. U.S. EDT.

The players

Indivior Pharmaceuticals, Inc.

A pharmaceutical company that is a leader in long-acting injectable treatments for opioid use disorder (OUD).

Joe Ciaffoni

The Chief Executive Officer of Indivior Pharmaceuticals.

Got photos? Submit your photos here. ›

What’s next

Investors will be able to access the recorded webcast presentation on Indivior's website after the live event.

The takeaway

Indivior's quarterly financial updates provide insight into the state of the addiction treatment market and the company's ongoing efforts to develop and commercialize its products for opioid use disorder, an area of significant public health importance.